Podcast

Pharmacy Focus: Psychedelic Pharmacy - Psilocybin-Assisted Therapy for Binge Eating Disorder

Jim Gilligan, PhD, discusses a phase 2 study investigating psilocybin-assisted therapy for binge eating disorder.

This month, we spoke with Jim Gilligan, PhD, to learn about a phase 2 study investigating the use of psilocybin-assisted therapy for the treatment of binge eating disorder.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Psychiatric pharmacist and patient -- Image credit: NanSan | stock.adobe.com
Psychiatric pharmacist -- Image credit: HBS | stock.adobe.com
Related Content
Medical form, diagnosis schizophrenia | Image Credit: Rawf8 | stock.adobe.com
July 10th 2025

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Danielle Valletti, Assistant Editor
COBRRA Trial Results Raise Questions About VTE Management
July 15th 2025

COBRRA Trial Results Raise Questions About VTE Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Community Pharmacist Collaboration Expands Access to Long-Acting Injectable Antipsychotics
June 9th 2025

Community Pharmacist Collaboration Expands Access to Long-Acting Injectable Antipsychotics

Aislinn Antrim, Managing Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Burned out pharmacy resident -- Image credit: Anela Ramba/peopleimages.com | stock.adobe.com
June 6th 2025

Resident Mental Health Matters

Brianne Perry, PharmD
Illustration of opioid pills spilling out of pill bottle | Image Credit: © Nats - stock.adobe.com
May 21st 2025

Managing Opioid Complexity: The Role of Pharmacists in OUD and C-POD Care

Alexandra Gerlach, Associate Editor